The present invention generally relates to apparatus and methods employed in minimally invasive surgical procedures and more particularly to various aspects of apparatus and methods for separating and/or supporting tissue layers, especially in the disc space of the spine.
A variety of physical conditions involve two tissue surfaces that, for diagnosis or treatment of the condition, need to be separated or distracted or maintained in a separated condition from one another and then supported in a spaced-apart relationship. Such separation or distraction may be to gain exposure to selected tissue structures, to apply a therapeutic pressure to selected tissues, to return or reposition tissue structures to a more normal or original anatomic position and form, to deliver a drug or growth factor, to alter, influence or deter further growth of select tissues or to carry out other diagnostic or therapeutic procedures. Depending on the condition being treated, the tissue surfaces may be opposed or contiguous and may be bone, skin, soft tissue, or a combination thereof.
One location of the body where tissue separation is useful as a corrective treatment is in the spinal column. Developmental irregularities, trauma, tumors, stress and degenerative wear can cause defects in the spinal column for which surgical intervention is necessary. Some of the more common defects of the spinal column include vertebral compression fractures, degeneration or disruption of an intervertebral disc and intervertebral disc herniation. These and other pathologies of the spine are often treated with implants that can restore vertebral column height, immobilize or fuse adjacent vertebral bones, or function to provide flexibility and restore natural movement of the spinal column. Accordingly, different defects in the spinal column require different types of treatment, and the location and anatomy of the spine that requires corrective surgical procedures determines whether an immobilizing implantable device or a flexible implantable device is used for such treatment.
In a typical spinal corrective procedure involving distraction of tissue layers, damaged spinal tissue is removed or relocated prior to distraction. After the damaged tissue has been removed or relocated, adjacent spinal tissue layers, such as adjacent bone structures, are then distracted to separate and restore the proper distance between the adjacent tissue layers. Once the tissue layers have been separated by the proper distance, an immobilizing or flexible device, depending on the desired treatment, is implanted between the tissue layers. In the past, the implantable treatment devices have been relatively large cage-like devices that require invasive surgical techniques which require relative large incisions into the human spine. Such invasive surgical techniques often disrupt and disturb tissue surrounding the surgical site to the detriment of the patient.
Therefore, there remains a need for implantable treatment devices and methods that utilize minimally invasive procedures.
Such methods and devices may be particularly needed in the area of intervertebral or disc treatment. The intervertebral disc is divided into two distinct regions: the nucleus pulposus and the annulus fibrosus. The nucleus lies at the center of the disc and is surrounded and contained by the annulus. The annulus contains collagen fibers that form concentric lamellae that surround the nucleus and insert into the endplates of the adjacent vertebral bodies to form a reinforced structure. Cartilaginous endplates are located at the interface between the disc and the adjacent vertebral bodies.
The intervertebral disc is the largest avascular structure in the body. The cells of the disc receive nutrients and expel waste by diffusion through the adjacent vascularized endplates. The hygroscopic nature of the proteoglycan matrix secreted by cells of the nucleus operates to generate high intra-nuclear pressure. As the water content in the disc increases, the intra-nuclear pressure increases and the nucleus swells to increase the height of the disc. This swelling places the fibers of the annulus in tension. A normal disc has a height of about 10-15 mm.
There are many causes of disruption or degeneration of the intervertebral disc that can be generally categorized as mechanical, genetic and biochemical. Mechanical damage includes herniation in which a portion of the nucleus pulposus projects through a fissure or tear in the annulus fibrosus. Genetic and biochemical causes can result in changes in the extracellular matrix pattern of the disc and a decrease in biosynthesis of extracellular matrix components by the cells of the disc. Degeneration is a progressive process that usually begins with a decrease in the ability of the extracellular matrix in the central nucleus pulposus to bind water due to reduced proteoglycan content. With a loss of water content, the nucleus becomes desiccated resulting in a decrease in internal disc hydraulic pressure, and ultimately to a loss of disc height. This loss of disc height can cause the annulus to buckle with non-tensile loading and the annular lamellae to delaminate, resulting in annular fissures. Herniation may then occur as rupture leads to protrusion of the nucleus.
Proper disc height is necessary to ensure proper functionality of the intervertebral disc and spinal column. The disc serves several functions, although its primary function is to facilitate mobility of the spine. In addition, the disc provides for load bearing, load transfer and shock absorption between vertebral levels. The weight of the person generates a compressive load on the discs, but this load is not uniform during typical bending movements. During forward flexion, the posterior annular fibers are stretched while the anterior fibers are compressed. In addition, a translocation of the nucleus occurs as the center of gravity of the nucleus shifts away from the center and towards the extended side.
Changes in disc height can have both local and global effects. Decreased disc height results in increased pressure in the nucleus, which can lead to a decrease in cell matrix synthesis and an increase in cell necrosis and apoptosis. In addition, increases in intra-discal pressure create an unfavorable environment for fluid transfer into the disc, which can cause a further decrease in disc height.
Decreased disc height also results in significant changes in the global mechanical stability of the spine. With decreasing height of the disc, the facet joints bear increasing loads and may undergo hypertrophy and degeneration, and may even act as a source of pain over time. Decreased stiffness of the spinal column and increased range of motion resulting from loss of disc height can lead to further instability of the spine, as well as back pain.
Radicular pain may result from a decrease in foraminal volume caused by decreased disc height. Specifically, as disc height decreases, the volume of the foraminal canal, through which the spinal nerve roots pass, decreases. This decrease may lead to spinal nerve impingement, with associated radiating pain and dysfunction.
Finally, adjacent segment loading increases as the disc height decreases at a given level. The discs that must bear additional loading are now susceptible to accelerated degeneration and compromise, which may eventually propagate along the destabilized spinal column.
In spite of all of these detriments that accompany decreases in disc height, where the change in disc height is gradual many of the ill effects may be “tolerable” to the spine and patient and may allow time for the spinal system to adapt to the gradual changes. However, the sudden decrease in disc volume caused by the surgical removal of the disc or disc nucleus may increase the local and global problems noted above.
Many disc defects are treated through a surgical procedure, such as a discectomy in which the nucleus pulposus material is removed. During a total discectomy, a substantial amount (and usually all) of the volume of the nucleus pulposus is removed and immediate loss of disc height and volume can result. Even with a partial discectomy, loss of disc height can ensue. Discectomy alone is the most common spinal surgical treatment, frequently used to treat radicular pain resulting from nerve impingement by disc bulge or disc fragments contacting the spinal neural structures.
The discectomy may be followed by an implant procedure in which a prosthesis is introduced into the cavity left in the disc space when the nucleus material is removed. Thus far, the most common prosthesis is a mechanical device or a “cage” that is sized to restore the proper disc height and is configured for fixation between adjacent vertebrae. These mechanical solutions take on a variety of forms, including solid kidney-shaped implants, hollow blocks filled with bone growth material, push-in implants and threaded cylindrical cages.
A challenge in the use of a posterior procedure to install spinal prosthesis devices is that a device large enough to contact the end plates and expand the space between the end plates of the same or adjacent vertebra must be inserted through a limited space. In the case of procedures to increasing intervertebral spacing, the difficulties are further increased by the presence of posterior osteophytes, which may cause “fish mouthing” or concavity of the posterior end plates and result in very limited access to the disc. A further challenge in degenerative disc spaces is the tendency of the disc space to assume a lenticular shape, which requires a relatively larger implant than often is easily introduced without causing trauma to the nerve roots. The size of rigid devices that may safely be introduced into the disc space is thereby limited.
While cages of the prior art have been generally successful in promoting fusion and approximating proper disc height, typically these cages have been inserted from the posterior approach, and are therefore limited in size by the interval between the nerve roots. Further, it is generally difficult to implant from the posterior approach a cage that accounts for the natural lordotic curve of the lumber spine.
It is desirable to reduce potential trauma to the nerve roots and yet still allow restoration or maintenance of disc space height in procedures involving vertebrae fusion devices and disc replacement, containment of the nucleus of the disc or prevention of herniation of the nucleus of the disc. In general minimally invasive surgical techniques reduce surgical trauma, blood loss and pain. However, despite the use of minimally invasive techniques, the implantation of cage devices for treating the spine typically involves nerve root retraction, an inherently high risk procedure. It is therefore desirable to reduce the degree of invasiveness of the surgical procedures required to implant the device, which may also serve to permit reduction in the pain, trauma, and blood loss as well as the avoidance and/or reduction of the nerve root retraction.
In minimally invasive procedures, to monitor placement, it is useful that implant devices inserted into spinal tissue be detectable using fluoroscopic imaging systems. However if a device is visible using X-ray technology, then the device can interfere with the detection and monitoring of spinal tissues, such as bone growing into the disc space after a vertebral fusion procedure. Additional advances would also be useful in this area.
There are several aspects of the present subject matter which may be embodied separately or together in the devices and systems described and claimed below. These aspects may be employed alone or in combination with other aspects of the subject matter described herein, and the description of these aspects together is not intended to preclude the use of these aspects separately or the claiming of such aspects separately or in different combinations as set forth in the claims appended hereto.
In one aspect, a tissue distraction device includes first and second elongated members. The first and second elongated members are insertable between tissue layers and adapted to define a structure in situ having a dimensional aspect in a direction extending between the tissue layers. The tissue distraction device also includes an augmenting elongated member insertable between and in contact with the first and second elongated members to spread the first and second elongated members apart to increase the dimensional aspect of at least a portion of the structure in situ. The augmenting, first, and second elongated members are sufficiently flexible to change between a generally linear configuration and a generally less linear configuration. A locking member is configured to be secured to one of the elongated members at a plurality of locations to lock the augmenting, first, and second elongated members in the generally less linear configuration.
In another aspect, a tissue distraction device includes first and second elongated members defining a generally annular configuration. An augmenting member is fully received between the first and second elongated members and having a linear extent less than the linear extents of the first and second elongated members.
In yet another aspect, a method is provided for assembling a structure in vivo between two body tissue layers comprising first and second elongated members, an augmenting elongated member, and a locking member secured to one of the elongated members at a first location. The method includes delivering the first and second elongated members toward a location between two body tissue layers in a generally linear configuration to define at least a portion of a structure having a dimensional aspect in a direction extending generally from one of the body tissue layers to the other body tissue layer. The configurations of the first and second elongated members is changed to a generally less linear configuration. The augmenting elongated member is inserted between and in contact with the first and second elongated members to spread the first and second elongated members apart to increase the dimensional aspect of at least a portion of the structure. The locking member is secured to one of the elongated members at a second location to lock the first and second elongated members in the generally less linear configuration.
The embodiments disclosed herein are for the purpose of providing a description of the present subject matter, and it is understood that the subject matter may be embodied in various other forms and combinations not shown in detail. Therefore, specific embodiments and features disclosed herein are not to be interpreted as limiting the subject matter as defined in the accompanying claims.
The devices and methods of the present invention provide multiple features of distraction devices, distraction device support structures and deployment systems that can be used to actively separate tissue layers by engaging them and forcing them apart, or to support the separation of tissue layers separated by the distraction device itself or by other devices or processes or a combination of these.
As used herein, the terms “distraction device” and “support structure” are intended to have a general meaning and is not limited to devices that only actively separate tissue layers, only support tissue layers or only both actively separate and support tissue layers. For example, the distraction device and support structure in general can be used to actively separate layers of tissue and then be removed after such separation, or the distraction device and the support structure could be used to support layers of tissue that have been previously separated by a different device. Alternatively, the distraction device and support structure can be used to actively separate the layers of tissue and remain in place to support the layers of tissue in order to maintain such separation. Unless more specifically set forth in the claims, as used herein, “distraction device” and “support structure” encompass any and all of these. In addition, it should be noted that the references to “first” and “second” members or devices are for convenience in the written description. They may be combined to provide a single distraction assembly or structure of selected distraction height, and the assembly is not limited to any particular number of “devices” or “members.” In keeping with the broader aspects of the present invention the specific number of “devices” or “members” can be varied according to the intended usage or design considerations.
It should also be understood that various embodiments of the device, system and method of the present invention are illustrated for purposes of explanation in vertebral fusion procedures and/or replacement of removed discs. However, in its broader aspects, the various features of the present invention are not limited to these particular applications and may be used in connection with other tissue layers, such as soft tissue layers, although it has particular utility and benefit in treatment of vertebral conditions within intervertebral discs or disc spaces.
One embodiment of a distraction device or support structure or implant 10 is shown in
Elongated members according to the present disclosure may be manufactured using a number of techniques, including machining or milling techniques. Milling can include cutting elongated members from solid blocks or rods of PEEK or other suitable material. Elongated members may also be manufactured using molding techniques. Molding techniques include co-molding various materials together to form an elongated member, as well as molding a second material over a first material. Elongated members may also be manufactured by injection molding or extrusion processes. In addition, the elongated members of the present invention may be manufactured with electrical discharge machining processes and by rapid prototyping methods including fused deposition modeling (FDM) and stereo lithography (SLA) techniques.
Preferably, the elongated members which form the distraction device 10 have a generally linear configuration for insertion into tissue or between tissue layers.
When deployed into or between tissue, the elongated members change configuration, preferably by flexing or bending, to a generally less linear configuration to define the distraction device or support structure 10. In a preferred embodiment, which is shown in
In some embodiments, the elongated members may also be designed with additional features that limit or control the nature of the bending or shape change that the elongated members may experience. For example,
Additional features may be added to enhance or limit the flexibility of the elongated members of the distraction devices, including grooves, slots, channels, and pockets and teeth or other extensions or members of various shapes. The slots, grooves, channels, and pockets may be placed, for example, in a linear pattern or spirally around the body of the elongated member. Through holes or apertures may also assist in providing flexibility as well as serve as lumens for various wires or filaments, as will be discussed in greater detail. The placement of a greater number of these features in one region of an elongated member can make that region more or less flexible than other regions of the device with fewer or different flexibility enhancing or limiting features. In this manner, selected regions of the elongated member will be easier or more difficult to bend or deflect to assist the shaping of the distraction device 10 in a desired configuration, such as a circular, rectangular, or oval shape. Alternatively, the flexibility features can be located uniformly along a segment or the whole of the elongated member to provide regions of uniform flexibility.
Flexibility of the elongated members may also be achieved or varied by fabricating the device from a combination of materials with different degrees of flexibility. For instance, by located more rigid material on one side of an elongated member, the elongated member may be easier to bend or deflect toward that side. Particularly, if the elongated member is preformed into a desired in situ configuration (e.g., a curved configuration) and temporarily straightened for insertion, the more rigid material may tend to retain the desired configuration to a greater degree than the other material and form the desired configuration when the elongated member is introduced into the work space. Also, the elongated member can have alternating or different sections along its length that are made of different materials having different rigidity.
In another aspect of the present disclosure, the elongated members preferably have the ability to recover from temporary deformation. As noted previously, the elongated member(s) may be pre-set or pre-formed into a desired in situ shape and then temporarily reshaped, such as by straightening, for insertion. In this aspect, for instance, a pre-shaped elongated member may tend to recover its shape more quickly or completely in body-temperature spinal tissue after being in a less-curved condition during shipping and storage inside of a deployment cannula. In other embodiments, due to plastic creep or other material characteristics, the elongated members may not recover their original shape after extended deformation in the cannula, and an external force may be used to shape the elongated member after it is at least partially inserted into the work space.
In a specific example, elongated members manufactured from polymeric materials such as PEEK may be pre-shaped by placing the elongated member in a metal fixture or jig having a desired shape, such as an annular or arcuate shape, and then heating the elongated member to relieve the bending stress. For instance, the elongated member can be treated for about 5 minutes at about 160° C. For many polymeric materials, such as PEEK, the pre-shaping process biases the elongated member toward a desired shape yet still allows the elongated member to be deformed either in the cannula or in situ after the elongated member is inserted into a work space. In some embodiments, such as where the elongated members are comprised at least in part of PEEK, the elongated members do not have shape memory material properties. Consequently, in some embodiments, particularly when PEEK is used, the elongated member does not return to its original shape without the additional application of an external force to shape the member. Such external force may be applied, for example, by a pull wire, as will be described in more detail.
In some embodiments, the deformation of the elongated members is constrained in a first axis and allowed in a plane at an angle to the first axis to allow deflection in a different plane. For instance, in
Looking more particularly at the augmenting elongated member 16, it is configured to be inserted and slid between the first and second elongated members 12 and 14 to increase the height of or otherwise augment the distraction device 10. The degree of height increase of the distraction device 10 is dependent upon the height of the augmenting elongated member 16. For instance, a thicker augmenting elongated member (i.e., an augmenting elongated member having a relatively great height) will cause a greater increase in the height of the distraction device than a thinner augmenting elongated member (i.e., an augmenting elongated member having a relatively small height). In embodiments inserted into the disc space to distract adjacent vertebral bodies, the height of the distraction device 10 (which is generally equal to the combined heights of the bodies of the constituent elongated members) is preferably sufficient to restore the disc to its normal height or thereabout, which will depend on the size of the patient and the disc's location in the spinal column. The height of the distraction device 10 can be, for example, from about 5 mm to about 15 mm. More particularly, the height can be from about 7.5 mm to about 13.5 mm, or about 9 mm to about 12 mm and ranges therein. For relatively short individuals or children, the disc size and, consequently, the height of the support structure can be, for example, from about 5 mm to about 7 mm. For relatively tall individuals, the disc height and, consequently, the height of the support structure can be, for example, from about 9 mm to about 15 mm or greater potentially. In other applications, the dimensions (including the heights) of the individual elongated members and the resulting distraction device may vary without departing from the scope of the present disclosure.
In one embodiment, the thickness of the augmenting elongated member can be different along its length to cause different amounts of additional distraction along the length of the distraction device. For instance, the proximal portion of the augmenting member may be thicker (taller) than the distal portion of the augmenting member, in which case the increase in the height of the proximal portion of the distraction device will be greater than the augmentation in the height of the distal portion of the device. The ability to create a greater increase in height in one region of a distraction device allows for adjustments in the curvature of the spine of a patient. For instance, a collapsed disc in the lumbar region of the spine can result in the loss of the normal lordosis in the lumbar region of the spine. The insertion of an augmenting elongated member of variable thickness/height between upper and lower elongated members deployed in a collapsed lumbar disc can restore the lumbar disc to the more normal morphology of a greater height on its anterior region as compared to its posterior region. In such a situation, the augmenting member may have a greater height at its central region between the distal and proximal ends than at either the proximal end or distal end.
Preferably, once augmented, the height of the distraction device 10 is fixed and is not adjustable or variable, while the augmenting member 16 is preferably fixed in position between the first and second elongated members 12 and 14 and not removable. The first and second elongated members 12 and 14 may have corresponding contoured surfaces or features that mechanically or frictionally cooperate or mate to assist in maintaining the positions of the first and second elongated members 12 and 14 relative to each other and within a work space to increase the stability of the distraction device 10. For example, in one embodiment, the upper surface 22 of the second elongated element 14 (as shown in greater detail in
The top side or surface 40 of the first elongated member 12 may contain a contoured portion 42 (
As shown in
In a preferred embodiment, the raised ribs 48 and 50 and grooves 42 and 46 are configured to prevent vertical separation of the elongated members. For example, the illustrated raised ribs 48 and 50 are generally T-shaped, while the grooves 42 and 46 have relatively narrow necked-down portions 58. As the augmenting elongated member 16 is inserted between the first and second elongated members 12 and 14, the relatively wide heads 60 of the raised ribs 48 and 50 are received by the grooves 42 and 46, with the necked-down portions 58 positioned between the wide heads 60 and the body of the augmenting elongated member 16. By such a configuration, the rib heads 60 and the necked-down portions 58 of the grooves 42 and 46 prevent the elongated members from being vertically separated after at least partial insertion of the augmenting elongated member 16 between the first and second elongated members 12 and 14. This locking mechanism may assist in preventing the elongated members from slipping relative to one another in response to the stresses a patient's normal movements place on the implant 10.
The guiding of the locking protrusions 64 into the recesses 62 may be assisted by locating them along the contoured surfaces of the associated elongated member. As seen in
As illustrated, the locking protrusions 64 may be cylindrically shaped, but it may be otherwise shaped without departing from the scope of the present disclosure. If provided as a cylinder, the diameter of the locking protrusion 64 may be greater than the width of the associated raised rib 48, 50 (
The locking protrusions 64 may be any suitable size or material, such as cylinders or pins made of a radiopaque material (e.g., tantalum or gold or platinum) with a diameter ranging from about 0.25 mm to about 2 mm. By providing the locking protrusions 64 as radiopaque members, they assist the surgeon in positioning the elongated members in situ. For a similar effect, the interlocking recesses 62 may be lined with tantalum or another radiopaque material. In other embodiments, other portions of the elongated members may be radiopaque to further assist in determining the locations of the elongated members in situ. In one exemplary embodiment, the elongated members are manufactured from radiolucent materials, such as PEEK (which may be a preferred material), polyetherketoneketone (PEKK), nylon and ultrahigh molecular weight polyethylenes (UMPE). By providing discrete radiopaque regions or markers in known locations within the elongated members, the surgeon may determine the locations and relative orientations of the elongated members in situ.
In addition to the foregoing features, the elongated members may further include internal cavities or passages or lumen for receiving various wires or filaments. For example, as described above, the shape of the distraction device 10 may be assisted, controlled, and/or adjusted as the elongated members are being deployed between the tissues to be distracted. The forces required to control the shape of the elongated members are preferably compatible with typical hand-held delivery systems and tools. For instance, the shape of an elongated member may be controlled with pull wire systems deployed either inside the elongated member and/or outside the elongated member. In the illustrated embodiment, the shape of the first and second elongated members 12 and 14 is controlled during insertion by applying a greater force to one side of the elongated members than is applied to the other side using a pull wire 74 (
In the embodiment of
In systems such as the one illustrated in
In other embodiments, including the illustrated embodiment, a separate mechanism may be provided to maintain the position of the first and second elongated members 12 and 14 with respect to the deployment cannula 82 while the augmenting elongated member 16 is inserted therebetween. As shown in
The anchor wires 84 may provide little resistance to the deployment of the first and second elongated members 12 and 14, permitting the first and second elongated members 12 and 14 to exit the distal end 80 of the deployment cannula 82. The length and tension of the anchor wires 84 are adjustable to provide increased tension after the first and second elongated members 12 and 14 have exited the cannula 82. The anchor wires 84 keep the first and second elongated members 12 and 14 in close proximity to the distal end 80 of the cannula 82, thereby allowing the insertion of the augmenting elongated member 16 between the first and second elongated members 12 and 14 without having to increase the tension on the pull wire 74. This may be advantageous, as applying excessive tension to the pull wire 74 may move the first and second elongated members 12 and 14 to an undesirable curved configuration during insertion of the augmenting elongated member 16 therebetween.
After the implant 10 has been deployed and properly positioned, the anchor wires 84 may be detached from the first and second elongated members 12 and 14. In one embodiment, after the pull wire 84 has been removed from the implant 10 (e.g., by cutting it and applying a proximally directed force to both of its ends), a distally directed force may be applied to the implant 10 (e.g., pushing the implant 10 approximately 2 mm further from its deployed position) while the tension in the anchor wires 84 is maintained. Doing so effectively increases the tension on the anchor wires 84, which increased tension will cause the enlarged ends 88 of the anchor wires 84 to enter (
As shown in
As noted above, the augmenting elongated member 16 may include a locking feature or mechanism or member in the form of a locking wire or cable or tether or filament 18, which is illustrated in
An interior passage or lumen or cavity 104 communicates with the interior cavity 100, with the locking member 18 extending distally from the fixed end 94 through the interior passage 104. The interior passage 104 leads to the distal end 56 of the augmenting elongated member 16, where the locking member 18 exits the augmenting elongated member 16 and loops back toward the proximal end 98 of the augmenting elongated member 16, as shown in
At or adjacent to the proximal end 98 of the augmenting elongated member 16, the locking member 18 reenters the interior of the augmenting elongated member 16 from the lateral groove 106 via a bore 110 extending from one lateral side of the augmenting elongated member 16 toward the other lateral side, as shown in
In the illustrated embodiment, the bore 110 causes the locking member 18 to reenter the interior cavity 100 of the augmenting elongated member 16 in a region directly adjacent to the spacer 102, but separated from the fixed end 94 of the locking member 18 by the spacer 102. This portion of the locking member 18 extends along the width of the spacer 102 until it reaches a longitudinally extending bore 112 that communicates with the laterally extending bore 110, as best shown in
The proximal end 98 of the illustrated augmenting elongated member 16 also includes a fastener 114 (e.g., a set screw) positioned within a longitudinal fastener bore 116 in communication with the spacer 102, with a portion of the free end 96 of the locking member 18 positioned between the fastener 114 and the spacer 102. The fastener 114 extends between an outer end 118 and an inner end 120 (
The inner end 120 of the fastener 114 is configured to have a cutting or shearing surface that severs the locking member 18 when brought into contact therewith with sufficient force. In the illustrated embodiment, the spacer 102 includes a retaining surface 122 and a cutting surface 124 facing the fastener 114 and separated by a step, with the cutting surface 124 positioned adjacent to and proximal of the retaining surface 122 (i.e., closer to the fastener 114), as shown in
By so securing the locking member 18 to the augmenting elongated member 16 at two locations (both of which are at or adjacent to the proximal end 98 of the augmenting elongated member 16 in the illustrated embodiment), the locking member 18 prevents the configuration of the augmenting elongated member 16 from changing. Locking the augmenting elongated member 16 into a particular configuration also effectively locks the first and second elongated members 12 and 14 (as well as the distraction device 10) into their current configuration, due to the locking relationship between the various elongated members, as described above. Preferably, the distraction device 10 is shaped into its final configuration prior to the fastener 114 locking the locking member 18 in place, thereby locking the distraction device 10 in its final configuration for long-term residence within the work space, as will be described in greater detail herein.
While the locking member 18 is described and illustrated as being associated with and secured to the augmenting elongated member 16, it should be understood that the locking member 18 may be associated with one of the other elongated members 12 and 14 and secured to multiple locations of either to lock the distraction device 10 in a particular configuration. Furthermore, it is also within the scope of the present disclosure for a plurality of similarly or differently configured locking members to be provided and associated with one or more of the elongated members. Additionally, rather than the locking member 18 being secured at multiple locations to an individual elongated member, it is also within the scope of the present disclosure for the locking member 18 to be secured at one location of one of the elongated members and at a second location of one of the other elongated members. For example, the locking member 18 may be secured to the augmenting elongated member 16 at a fixed end 94 and extend from the proximal end 98 of the augmenting elongated member 16 to exit the distal end 56 of the augmenting elongated member 16, as described above. After exiting the distal end 56 of the augmenting elongated member 16, the free end 96 of the locking member 18 may be secured to one of the other elongated members by any suitable means, rather than being secured at a second location of the augmenting elongated member 16. It should be understood that so securing the locking member 18 at separate locations of different elongated members will have a similar effect to securing the locking member 18 to separate locations of the same elongated member, in that the resulting distraction device 10 will be locked into a particular configuration.
The wires or cables or filaments or tethers described herein may consist of materials suitable for sterilization and compatible for temporary contact with animal, including human tissue. Metal wires may be made from stainless steel, Nitinol, or other suitable metal wires, for example. Non-metal wires may be made from natural fibers and polymeric fibers including polyethylene, UHPE, Victrex, PET, or similar medical-grade polymers.
Tensile forces may be applied to the wires or cables or filaments or lines described herein by any suitable source. In a preferred embodiment, the tensile forces are applied via a delivery device 126 (
In the illustrated embodiment, the free ends of the various lines pass through the deployment cannula 82 to be attached to various attachment points located within the delivery device 126. The lines may be attached to the delivery device 126 by any of a number of suitable means, including releasable mechanical features such as screws, clamps, crimps, and ferrules and other like means. The lines may also be attached by knotting, gluing or pinching them to the delivery device 126.
In the illustrated embodiment, the pull wire 74 is associated with a slider 128 that is received within a central opening or cavity 130 of the delivery device 126 that is substantially coaxial with the deployment cannula 82. The slider 128 is movable along the longitudinal axis of the delivery device 126 within the central cavity 130 to adjust the tension in the pull wire 74, thereby adjusting the curvature of the first and second elongated members 12 and 14, as described above. In the illustrated embodiment, the outer surface of the slider 128 is threaded to engage threads of the central cavity 130, such that rotation of the slider 128 about its central axis will advance it proximally and distally through the central cavity 130. It is also within the scope of the present disclosure for the slider 128 to move with respect to the remainder of the delivery device 126 without rotating (e.g., by translational movement). If the slider 128 is configured to rotate while moving through the central cavity 130, an insertion knob 132 may be associated with the slider 128 and extend outside of the central cavity 130 to be rotated in order to rotate and move the slider 128 through the central cavity 130.
In the illustrated embodiment, the anchor wires 84 are associated with a capstan or spool or spindle 134, with the capstan 134 controlling the tension on the anchor wires 84. The capstan 134 may also limit the total amount of line released to hold the deployed first and second elongated members 12 and 14 at the desired location in close proximity to the distal end 80 of the cannula 82. The tension in the anchor wires 84 may also be controlled by other means such as springs, resilient means, sliding mechanisms, rotating mechanisms, moving mechanisms, pulleys, stretchable lines and the like.
The free end 96 of the locking member 18 may also be adjustably secured to a rotary mechanism (similar to the pull wire 74 and the anchor wires 84) or to a non-rotational component of the delivery device 126 or may extend through the delivery device 126 without being secured thereto.
As described above, after the distraction device 10 has been deployed, the pull wire 74 may be severed and removed. In the illustrated embodiment, the delivery device 126 includes a shearing assembly 136 (
A tool kit may include a number of related components and tools (illustrated in
Optionally, all or a portion of the nucleus pulposus is removed and the endplates of the adjacent vertebrae are scraped to cause bleeding and promote the fusion of bone graft material to the vertebral endplates. Sizing paddles 148, 150 (
When the appropriate deployment cannula 82 and distraction device 10 have been selected, a distal end 80 of the deployment cannula 82 is advanced through the access port and into the disc space (
Because the first and second elongated members 12 and 14 together clear the minimum disc height, they can be pushed out of the deployment cannula 82 and into the disc space easily using the delivery device 126 or the like. For delivery, the physician begins to push in the first and second elongated members 12 and 14 simultaneously out of the cannula 82 little by little, for example by using a pusher or plunger or other suitable actuating means, such as a rotary actuator. Between pushes, the physician may check the curvature of the partially inserted first and second elongated members 12 and 14 (
By the time the first and second elongated members 12 and 14 are entirely out of the cannula 82 and within the disc space, the distal or leading ends 28 and 24 of the first and second elongated members 12 and 14 may be adjacent to and/or in contact with the proximal ends 52 and 54 of the first and second elongated members 12 and 14. If not, additional tension may be applied to the pull wire 74 until the distal or leading end 28 and 24 of the first and second elongated members 12 and 14 are adjacent to and/or in contact with the proximal ends 52 and 54 of the first and second elongated member 12 and 14. As shown in
With the first and second elongated members 12 and 14 fully deployed from the cannula 82 and in the generally annular configuration of
When first advanced out of the cannula 82, the augmenting elongated member 16 begins to wedge itself in between the first and second elongated members 12 and 14. Depending on the thickness (height) of the augmenting elongated member 16, some slack may need to be given at this point to the pull wire 74 and/or the anchor wires 84 to allow them to separate in a vertical direction (i.e., in a direction between the surfaces to be distracted or along the axis of the spine or the direction of distraction) to allow further advancement of the augmenting elongated member 16.
Once the physician confirms that the tip of the augmenting elongated member 16 is wedged securely and the raised ribs 48 and 50 and associated grooves 42 and 46 (if provided) of the three elongated members are engaged, the augmenting elongated member 16 is advanced slowly while checking for changes in the curvature of the distraction device 10. As before, the curvature can be adjusted in real time using the pull wire 74. In a preferred embodiment, the curvature may be adjusted automatically by developing tension in the pull wire 74 via a screw or rotational mechanism incorporated into or associated with the slider 128. The augmenting elongated member 16 is preferably pushed in all the way until its back face is flush with the back faces of the first and second elongated members 12 and 14 (
The physician then makes a final check of the implant placement and desired distraction. If satisfied, the physician detaches the pull wire 74 and anchor wires 84 from the implant 10 (as described above) and may remove the cannula 82 and associated delivery device 126. Even with the pull wire 74 detached from the implant 10, the reaction force applied to the implant 10 by the tissues being distracted should be sufficient to maintain the implant 10 in the illustrated generally annular configuration.
As shown in
The locking member 18, as described above, may separate from the lateral groove 106 in which it sits during (or after) insertion of the augmenting elongated member 16 to extend through the open interior or resident volume 108 defined by the implant 10. At this point, it may be advantageous for the locking member 18 to not be fully tensioned, otherwise it may obstruct the window 158, as shown in
As shown in
When the desired amount of bone graft material or bone filler material 156 has been introduced into the resident volume 108, the physician withdraws the funnel 152 and then applies a proximally directed force to the free end 96 of the locking member 18 (
The free end 96 of the locking member 18 being secured and severed, the severed portion may be removed from the disc space, along with the driver device 160, leaving only the fully deployed implant 10 in the disc space, as shown in
It should be understood that the above-described elongated members, distraction device, deployment tools, and methods are merely exemplary. For example,
In other embodiments, a separate fastener or fixture is not required to maintain the elongated member or distraction device in a generally annular configuration. For example,
It will be understood that the embodiments described above are illustrative of some of the applications of the principles of the present subject matter. Numerous modifications may be made by those skilled in the art without departing from the spirit and scope of the claimed subject matter, including those combinations of features that are individually disclosed or claimed herein. For these reasons, the scope hereof is not limited to the above description but is as set forth in the following claims, and it is understood that claims may be directed to the features hereof, including as combinations of features that are individually disclosed or claimed herein.
The present application is a reissue of U.S. Pat. No. 10,231,843 which issued Mar. 19, 2019, from U.S. patent application Ser. No. 15/276,147, filed Sep. 26, 2016, which is a continuation of U.S. patent application Ser. No. 13/803,322, filed Mar. 14, 2013, now U.S. Pat. No. 9,480,574, the contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2002021 | Rouse | May 1935 | A |
3807390 | Ostrowski et al. | Apr 1974 | A |
4846175 | Frimberger | Jul 1989 | A |
4862891 | Smith | Sep 1989 | A |
4863476 | Shepperd | Sep 1989 | A |
4898161 | Grundei | Feb 1990 | A |
5059193 | Kuslich | Oct 1991 | A |
5129889 | Hahn et al. | Jul 1992 | A |
5192327 | Brantigan | Mar 1993 | A |
5201742 | Hasson | Apr 1993 | A |
5219358 | Bendel et al. | Jun 1993 | A |
5267994 | Gentelia et al. | Dec 1993 | A |
5306310 | Siebels | Apr 1994 | A |
5342394 | Matsuno et al. | Aug 1994 | A |
5345945 | Hodgson et al. | Sep 1994 | A |
5366490 | Edwards et al. | Nov 1994 | A |
5374267 | Siegal | Dec 1994 | A |
5383884 | Summers | Jan 1995 | A |
5397304 | Truckai | Mar 1995 | A |
5397364 | Kozak et al. | Mar 1995 | A |
5423806 | Dale et al. | Jun 1995 | A |
5433739 | Sluijter et al. | Jul 1995 | A |
5445639 | Kuslich et al. | Aug 1995 | A |
5470043 | Marts et al. | Nov 1995 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5500012 | Brucker et al. | Mar 1996 | A |
5540696 | Booth, Jr. et al. | Jul 1996 | A |
5549679 | Kuslich | Aug 1996 | A |
5554163 | Shturman | Sep 1996 | A |
5571147 | Sluijter et al. | Nov 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5599346 | Edwards et al. | Feb 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5716416 | Lin | Feb 1998 | A |
5718707 | Mikhail | Feb 1998 | A |
5755661 | Schwartzman | May 1998 | A |
5755732 | Green et al. | May 1998 | A |
5755797 | Baumgartner | May 1998 | A |
5782832 | Larsen et al. | Jul 1998 | A |
5788713 | Dubach et al. | Aug 1998 | A |
5851214 | Larsen et al. | Dec 1998 | A |
5865809 | Moenning et al. | Feb 1999 | A |
5871501 | Leschinsky et al. | Feb 1999 | A |
5885217 | Gisselberg et al. | Mar 1999 | A |
5916166 | Reiss et al. | Jun 1999 | A |
5919235 | Husson et al. | Jul 1999 | A |
5980471 | Jafari | Nov 1999 | A |
5980504 | Sharkey et al. | Nov 1999 | A |
6007570 | Sharkey et al. | Dec 1999 | A |
6019765 | Thornhill et al. | Feb 2000 | A |
6039761 | Li et al. | Mar 2000 | A |
6059829 | Schläpfer et al. | May 2000 | A |
6099514 | Sharkey et al. | Aug 2000 | A |
6126660 | Dietz | Oct 2000 | A |
6126682 | Sharkey et al. | Oct 2000 | A |
6183517 | Suddaby | Feb 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6228022 | Friesem et al. | May 2001 | B1 |
6231609 | Mehdizadeh | May 2001 | B1 |
6245072 | Zdeblick | Jun 2001 | B1 |
6245107 | Ferree | Jun 2001 | B1 |
6277112 | Underwood et al. | Aug 2001 | B1 |
6332895 | Suddaby | Dec 2001 | B1 |
6375635 | Moutafis et al. | Apr 2002 | B1 |
6375682 | Fleischmann et al. | Apr 2002 | B1 |
6387130 | Stone et al. | May 2002 | B1 |
6409766 | Brett | Jun 2002 | B1 |
6419704 | Ferree | Jul 2002 | B1 |
6436142 | Paes et al. | Aug 2002 | B1 |
6454806 | Cohen et al. | Sep 2002 | B1 |
6468270 | Hovda et al. | Oct 2002 | B1 |
6488710 | Besselink | Dec 2002 | B2 |
6491690 | Goble et al. | Dec 2002 | B1 |
6500205 | Michelson | Dec 2002 | B1 |
6530926 | Davison | Mar 2003 | B1 |
6551319 | Lieberman | Apr 2003 | B2 |
6554833 | Levy et al. | Apr 2003 | B2 |
6558383 | Cunningham et al. | May 2003 | B2 |
6558386 | Cragg | May 2003 | B1 |
6558390 | Cragg | May 2003 | B2 |
6562033 | Shah et al. | May 2003 | B2 |
6582431 | Ray | Jun 2003 | B1 |
6592625 | Cauthen | Jul 2003 | B2 |
6595998 | Johnson et al. | Jul 2003 | B2 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6607505 | Thompson et al. | Aug 2003 | B1 |
6607530 | Carl et al. | Aug 2003 | B1 |
6620196 | Trieu | Sep 2003 | B1 |
6656178 | Veldhuizen et al. | Dec 2003 | B1 |
6670505 | Collins et al. | Dec 2003 | B1 |
6676665 | Foley et al. | Jan 2004 | B2 |
6714822 | King et al. | Mar 2004 | B2 |
6726684 | Woloszko et al. | Apr 2004 | B1 |
6733496 | Sharkey et al. | May 2004 | B2 |
6749605 | Ashley et al. | Jun 2004 | B2 |
6764491 | Frey et al. | Jul 2004 | B2 |
6767347 | Sharkey et al. | Jul 2004 | B2 |
6773432 | Clayman et al. | Aug 2004 | B1 |
6821276 | Lambrecht et al. | Nov 2004 | B2 |
6830570 | Frey et al. | Dec 2004 | B1 |
6878155 | Sharkey et al. | Apr 2005 | B2 |
6923811 | Carl et al. | Aug 2005 | B1 |
6939351 | Eckman | Sep 2005 | B2 |
6953458 | Loeb | Oct 2005 | B2 |
6964667 | Shaolian et al. | Nov 2005 | B2 |
6976949 | Winkler et al. | Dec 2005 | B2 |
7004970 | Cauthen, III et al. | Feb 2006 | B2 |
7008432 | Schlapfer et al. | Mar 2006 | B2 |
7025765 | Balbierz et al. | Apr 2006 | B2 |
7052516 | Cauthen, III et al. | May 2006 | B2 |
7056321 | Pagliuca et al. | Jun 2006 | B2 |
7069087 | Sharkey et al. | Jun 2006 | B2 |
7087055 | Lim et al. | Aug 2006 | B2 |
7087058 | Cragg | Aug 2006 | B2 |
7114501 | Johnson et al. | Oct 2006 | B2 |
7124761 | Lambrecht et al. | Oct 2006 | B2 |
7144397 | Lambrecht et al. | Dec 2006 | B2 |
7179225 | Shluzas et al. | Feb 2007 | B2 |
7204853 | Gordon et al. | Apr 2007 | B2 |
7211055 | Diederich et al. | May 2007 | B2 |
7241297 | Shaolian et al. | Jul 2007 | B2 |
7252686 | Carrison et al. | Aug 2007 | B2 |
7267687 | McGuckin, Jr. | Sep 2007 | B2 |
7282020 | Kaplan | Oct 2007 | B2 |
7309336 | Ashley et al. | Dec 2007 | B2 |
7318823 | Sharps et al. | Jan 2008 | B2 |
7318826 | Teitelbaum et al. | Jan 2008 | B2 |
7322962 | Forrest | Jan 2008 | B2 |
7331956 | Hovda et al. | Feb 2008 | B2 |
7331963 | Bryan et al. | Feb 2008 | B2 |
RE40156 | Sharps et al. | Mar 2008 | E |
7618458 | Biedermann et al. | Nov 2009 | B2 |
7682378 | Truckai et al. | Mar 2010 | B2 |
7753912 | Raymond et al. | Jul 2010 | B2 |
7758647 | Arnin et al. | Jul 2010 | B2 |
7771432 | Schwab et al. | Aug 2010 | B2 |
7776051 | Colleran et al. | Aug 2010 | B2 |
7824445 | Biro et al. | Nov 2010 | B2 |
7887568 | Ahlgren | Feb 2011 | B2 |
7901460 | Sherman | Mar 2011 | B2 |
7922767 | Sack et al. | Apr 2011 | B2 |
7947078 | Siegal | May 2011 | B2 |
7963915 | Bleich | Jun 2011 | B2 |
8021429 | Viker | Sep 2011 | B2 |
8025697 | McClellan, III et al. | Sep 2011 | B2 |
8083796 | Raiszadeh et al. | Dec 2011 | B1 |
8123750 | Norton et al. | Feb 2012 | B2 |
8128662 | Altarac et al. | Mar 2012 | B2 |
8137401 | Stad et al. | Mar 2012 | B2 |
8142507 | McGuckin, Jr. | Mar 2012 | B2 |
8246622 | Siegal et al. | Aug 2012 | B2 |
8252001 | Quimo et al. | Aug 2012 | B2 |
8252054 | Greenhalgh et al. | Aug 2012 | B2 |
8377070 | Gauthier | Feb 2013 | B2 |
8394102 | Garabedian et al. | Mar 2013 | B2 |
8454617 | Schaller et al. | Jun 2013 | B2 |
8454622 | Blain et al. | Jun 2013 | B2 |
8470043 | Schaller et al. | Jun 2013 | B2 |
8579980 | DeLurio et al. | Nov 2013 | B2 |
8591583 | Schaller et al. | Nov 2013 | B2 |
8628577 | Jimenez | Jan 2014 | B1 |
8632591 | Vila et al. | Jan 2014 | B2 |
8663332 | To et al. | Mar 2014 | B1 |
8685031 | Kleiner et al. | Apr 2014 | B2 |
8764806 | Abdou | Jul 2014 | B2 |
8906028 | Kleiner | Dec 2014 | B2 |
8968408 | Schaller et al. | Mar 2015 | B2 |
8974464 | Johnson et al. | Mar 2015 | B2 |
8979860 | Voellmicke et al. | Mar 2015 | B2 |
8986385 | Hall | Mar 2015 | B2 |
9034041 | Wolters et al. | May 2015 | B2 |
9039771 | Glerum et al. | May 2015 | B2 |
9161773 | Schaller et al. | Oct 2015 | B2 |
9308022 | Chitre et al. | Apr 2016 | B2 |
9351851 | Huffmaster et al. | May 2016 | B2 |
9480574 | Lee et al. | Nov 2016 | B2 |
9566170 | Schell et al. | Feb 2017 | B2 |
9642712 | Schaller et al. | May 2017 | B2 |
9827031 | Emery et al. | Nov 2017 | B2 |
9955961 | Huffmaster et al. | May 2018 | B2 |
10022243 | Emery et al. | Jul 2018 | B2 |
10231843 | Lee et al. | Mar 2019 | B2 |
10258228 | Genovese et al. | Apr 2019 | B2 |
10285821 | Schaller et al. | May 2019 | B2 |
10314605 | Huffmaster et al. | Jun 2019 | B2 |
10426629 | Schaller et al. | Oct 2019 | B2 |
10575963 | Schaller et al. | Mar 2020 | B2 |
10709577 | Lorang et al. | Jul 2020 | B2 |
10758286 | Ammerman et al. | Sep 2020 | B2 |
11224453 | Huffmaster et al. | Jan 2022 | B2 |
11298043 | Bankiewicz et al. | Apr 2022 | B2 |
11471145 | Pacheco-Serrant et al. | Oct 2022 | B2 |
11564811 | Lorang et al. | Jan 2023 | B2 |
11583327 | McHale et al. | Feb 2023 | B2 |
20010023348 | Ashley et al. | Sep 2001 | A1 |
20010029377 | Aebi et al. | Oct 2001 | A1 |
20010031981 | Evans et al. | Oct 2001 | A1 |
20020019637 | Frey et al. | Feb 2002 | A1 |
20020026197 | Foley et al. | Feb 2002 | A1 |
20020128716 | Cohen et al. | Sep 2002 | A1 |
20020147444 | Shah et al. | Oct 2002 | A1 |
20020156530 | Lambrecht et al. | Oct 2002 | A1 |
20020173813 | Peterson et al. | Nov 2002 | A1 |
20030009223 | Fehling et al. | Jan 2003 | A1 |
20030014047 | Woloszko et al. | Jan 2003 | A1 |
20030040796 | Ferree | Feb 2003 | A1 |
20030065358 | Frecker et al. | Apr 2003 | A1 |
20030083747 | Winterbottom et al. | May 2003 | A1 |
20030158545 | Hovda et al. | Aug 2003 | A1 |
20030158553 | Michelson | Aug 2003 | A1 |
20030187453 | Schlapfer et al. | Oct 2003 | A1 |
20030204189 | Cragg | Oct 2003 | A1 |
20030220650 | Major et al. | Nov 2003 | A1 |
20040002762 | Hawkins | Jan 2004 | A1 |
20040010315 | Song | Jan 2004 | A1 |
20040015218 | Finch et al. | Jan 2004 | A1 |
20040024463 | Thomas, Jr. et al. | Feb 2004 | A1 |
20040049180 | Sharps et al. | Mar 2004 | A1 |
20040059333 | Carl et al. | Mar 2004 | A1 |
20040064144 | Johnson et al. | Apr 2004 | A1 |
20040073216 | Lieberman | Apr 2004 | A1 |
20040087994 | Suddaby | May 2004 | A1 |
20040092988 | Shaolian et al. | May 2004 | A1 |
20040102774 | Trieu | May 2004 | A1 |
20040106940 | Shaolian et al. | Jun 2004 | A1 |
20040116922 | Hovda et al. | Jun 2004 | A1 |
20040127893 | Hovda | Jul 2004 | A1 |
20040133280 | Trieu | Jul 2004 | A1 |
20040148028 | Ferree et al. | Jul 2004 | A1 |
20040153064 | Foley et al. | Aug 2004 | A1 |
20040167625 | Beyar et al. | Aug 2004 | A1 |
20040193158 | Lim et al. | Sep 2004 | A1 |
20040230198 | Manzi et al. | Nov 2004 | A1 |
20040230309 | DiMauro et al. | Nov 2004 | A1 |
20040249464 | Bindseil et al. | Dec 2004 | A1 |
20040260305 | Gorensek et al. | Dec 2004 | A1 |
20050021030 | Pagliuca et al. | Jan 2005 | A1 |
20050021041 | Michelson | Jan 2005 | A1 |
20050033292 | Teitelbaum et al. | Feb 2005 | A1 |
20050038517 | Carrison et al. | Feb 2005 | A1 |
20050049623 | Moore et al. | Mar 2005 | A1 |
20050065610 | Pisharodi | Mar 2005 | A1 |
20050070911 | Carrison et al. | Mar 2005 | A1 |
20050080425 | Bhatnagar et al. | Apr 2005 | A1 |
20050090833 | DiPoto | Apr 2005 | A1 |
20050090899 | DiPoto | Apr 2005 | A1 |
20050107878 | Conchy | May 2005 | A1 |
20050113832 | Molz, IV et al. | May 2005 | A1 |
20050119750 | Studer | Jun 2005 | A1 |
20050131540 | Trieu | Jun 2005 | A1 |
20050131541 | Trieu | Jun 2005 | A1 |
20050137601 | Assell et al. | Jun 2005 | A1 |
20050137605 | Assell et al. | Jun 2005 | A1 |
20050149049 | Assell et al. | Jul 2005 | A1 |
20050165420 | Cha | Jul 2005 | A1 |
20050182414 | Manzi et al. | Aug 2005 | A1 |
20050182416 | Lim et al. | Aug 2005 | A1 |
20050187537 | Loeb et al. | Aug 2005 | A1 |
20050203527 | Carrison et al. | Sep 2005 | A1 |
20050222683 | Berry | Oct 2005 | A1 |
20050228391 | Levy et al. | Oct 2005 | A1 |
20050234493 | Carr et al. | Oct 2005 | A1 |
20050240171 | Forrest | Oct 2005 | A1 |
20050251134 | Woloszko et al. | Nov 2005 | A1 |
20050251177 | Saadat et al. | Nov 2005 | A1 |
20050256525 | Culbert et al. | Nov 2005 | A1 |
20050261683 | Veldhuizen et al. | Nov 2005 | A1 |
20050261684 | Shaolian et al. | Nov 2005 | A1 |
20050261692 | Carrison et al. | Nov 2005 | A1 |
20050273173 | Gordon et al. | Dec 2005 | A1 |
20050278027 | Hyde, Jr. | Dec 2005 | A1 |
20050278036 | Leonard et al. | Dec 2005 | A1 |
20060015131 | Kierce et al. | Jan 2006 | A1 |
20060025797 | Lock et al. | Feb 2006 | A1 |
20060030933 | DeLegge et al. | Feb 2006 | A1 |
20060036241 | Siegal | Feb 2006 | A1 |
20060041258 | Galea | Feb 2006 | A1 |
20060041295 | Osypka | Feb 2006 | A1 |
20060047178 | Winkler et al. | Mar 2006 | A1 |
20060052793 | Heinz | Mar 2006 | A1 |
20060058826 | Evans et al. | Mar 2006 | A1 |
20060058876 | McKinley | Mar 2006 | A1 |
20060074425 | Sutterlin et al. | Apr 2006 | A1 |
20060085070 | Kim | Apr 2006 | A1 |
20060089646 | Bonutti | Apr 2006 | A1 |
20060116689 | Albans | Jun 2006 | A1 |
20060129244 | Ensign et al. | Jun 2006 | A1 |
20060136064 | Sherman | Jun 2006 | A1 |
20060149268 | Truckai et al. | Jul 2006 | A1 |
20060161162 | Lambrecht et al. | Jul 2006 | A1 |
20060178666 | Cosman et al. | Aug 2006 | A1 |
20060189999 | Zwirkoski | Aug 2006 | A1 |
20060195091 | McGraw et al. | Aug 2006 | A1 |
20060195094 | McGraw et al. | Aug 2006 | A1 |
20060206116 | Yeung | Sep 2006 | A1 |
20060217811 | Lambrecht et al. | Sep 2006 | A1 |
20060224154 | Shadduck et al. | Oct 2006 | A1 |
20060224241 | Butler et al. | Oct 2006 | A1 |
20060229625 | Truckai et al. | Oct 2006 | A1 |
20060235418 | Gil et al. | Oct 2006 | A1 |
20060241577 | Balbierz et al. | Oct 2006 | A1 |
20060247600 | Yeung et al. | Nov 2006 | A1 |
20060247784 | Kim | Nov 2006 | A1 |
20060265076 | Carter et al. | Nov 2006 | A1 |
20060265077 | Zwirkoski | Nov 2006 | A1 |
20060287726 | Segal et al. | Dec 2006 | A1 |
20060287727 | Segal | Dec 2006 | A1 |
20060287729 | Segal et al. | Dec 2006 | A1 |
20060287730 | Segal et al. | Dec 2006 | A1 |
20070010848 | Leung et al. | Jan 2007 | A1 |
20070016273 | Scarborough et al. | Jan 2007 | A1 |
20070027545 | Carls et al. | Feb 2007 | A1 |
20070032791 | Greenhalgh | Feb 2007 | A1 |
20070050030 | Kim | Mar 2007 | A1 |
20070050032 | Gittings et al. | Mar 2007 | A1 |
20070055259 | Norton et al. | Mar 2007 | A1 |
20070055262 | Tomita et al. | Mar 2007 | A1 |
20070055275 | Schaller | Mar 2007 | A1 |
20070060935 | Schwardt et al. | Mar 2007 | A1 |
20070067035 | Falahee | Mar 2007 | A1 |
20070093822 | Dutoit et al. | Apr 2007 | A1 |
20070093899 | Dutoit et al. | Apr 2007 | A1 |
20070118219 | Hyde, Jr. | May 2007 | A1 |
20070123888 | Bleich et al. | May 2007 | A1 |
20070123903 | Raymond et al. | May 2007 | A1 |
20070123986 | Schaller et al. | May 2007 | A1 |
20070149978 | Shezifi et al. | Jun 2007 | A1 |
20070149990 | Palmer et al. | Jun 2007 | A1 |
20070162032 | Johnson et al. | Jul 2007 | A1 |
20070162062 | Norton et al. | Jul 2007 | A1 |
20070162127 | Peterman et al. | Jul 2007 | A1 |
20070162135 | Segal et al. | Jul 2007 | A1 |
20070168041 | Kadiyala | Jul 2007 | A1 |
20070168043 | Ferree | Jul 2007 | A1 |
20070173939 | Kim et al. | Jul 2007 | A1 |
20070175959 | Shelton, IV et al. | Aug 2007 | A1 |
20070191837 | Trieu | Aug 2007 | A1 |
20070198021 | Wales | Aug 2007 | A1 |
20070198025 | Trieu et al. | Aug 2007 | A1 |
20070208426 | Trieu | Sep 2007 | A1 |
20070213704 | Truckai et al. | Sep 2007 | A1 |
20070213733 | Bleich et al. | Sep 2007 | A1 |
20070213734 | Bleich et al. | Sep 2007 | A1 |
20070213735 | Saadat et al. | Sep 2007 | A1 |
20070225703 | Schmitz et al. | Sep 2007 | A1 |
20070233143 | Josse et al. | Oct 2007 | A1 |
20070255286 | Trieu | Nov 2007 | A1 |
20070255406 | Trieu | Nov 2007 | A1 |
20070255703 | Maruyama et al. | Nov 2007 | A1 |
20070260252 | Schmitz et al. | Nov 2007 | A1 |
20070260270 | Assell et al. | Nov 2007 | A1 |
20070260315 | Foley et al. | Nov 2007 | A1 |
20070265652 | Assell et al. | Nov 2007 | A1 |
20070265691 | Swanson | Nov 2007 | A1 |
20070276406 | Mahoney et al. | Nov 2007 | A1 |
20070299521 | Glenn et al. | Dec 2007 | A1 |
20080009826 | Miller et al. | Jan 2008 | A1 |
20080009828 | Miller et al. | Jan 2008 | A1 |
20080009847 | Ricart et al. | Jan 2008 | A1 |
20080009875 | Sankaran et al. | Jan 2008 | A1 |
20080009876 | Sankaran et al. | Jan 2008 | A1 |
20080009877 | Sankaran et al. | Jan 2008 | A1 |
20080015639 | Bjork et al. | Jan 2008 | A1 |
20080021435 | Miller et al. | Jan 2008 | A1 |
20080027407 | Miller et al. | Jan 2008 | A1 |
20080033465 | Schmitz et al. | Feb 2008 | A1 |
20080058707 | Ashley et al. | Mar 2008 | A1 |
20080065080 | Assell et al. | Mar 2008 | A1 |
20080065092 | Assell et al. | Mar 2008 | A1 |
20080065093 | Assell et al. | Mar 2008 | A1 |
20080065094 | Assell et al. | Mar 2008 | A1 |
20080071356 | Greenhalgh et al. | Mar 2008 | A1 |
20080086157 | Stad et al. | Apr 2008 | A1 |
20080114367 | Meyer | May 2008 | A1 |
20080147113 | Nobis et al. | Jun 2008 | A1 |
20080161809 | Schmitz et al. | Jul 2008 | A1 |
20080177259 | Wu | Jul 2008 | A1 |
20080183204 | Greenhalgh et al. | Jul 2008 | A1 |
20080221687 | Viker | Sep 2008 | A1 |
20080228135 | Snoderly | Sep 2008 | A1 |
20080234687 | Schaller et al. | Sep 2008 | A1 |
20080249628 | Altarac et al. | Oct 2008 | A1 |
20080287995 | Gauthier | Nov 2008 | A1 |
20080294171 | Boehm, Jr. et al. | Nov 2008 | A1 |
20080300636 | Carli et al. | Dec 2008 | A1 |
20090012612 | White et al. | Jan 2009 | A1 |
20090024217 | Levy et al. | Jan 2009 | A1 |
20090105711 | Mitchell et al. | Apr 2009 | A1 |
20090143716 | Lowry et al. | Jun 2009 | A1 |
20090157187 | Richelsoph | Jun 2009 | A1 |
20090171390 | Sankaran | Jul 2009 | A1 |
20090198241 | Phan | Aug 2009 | A1 |
20090198245 | Phan | Aug 2009 | A1 |
20090234454 | Siegal | Sep 2009 | A1 |
20100030216 | Arcenio | Feb 2010 | A1 |
20100114179 | Moore et al. | May 2010 | A1 |
20100131005 | Conlon | May 2010 | A1 |
20100179578 | Tannoury et al. | Jul 2010 | A1 |
20100185291 | Jimenez et al. | Jul 2010 | A1 |
20100198263 | Siegal et al. | Aug 2010 | A1 |
20100228091 | Widenhouse et al. | Sep 2010 | A1 |
20100249798 | Sournac et al. | Sep 2010 | A1 |
20100262147 | Siegal et al. | Oct 2010 | A1 |
20100262242 | Chavatte et al. | Oct 2010 | A1 |
20100268234 | Aho et al. | Oct 2010 | A1 |
20100286782 | Schaller et al. | Nov 2010 | A1 |
20100298864 | Castro | Nov 2010 | A1 |
20110015638 | Pischl et al. | Jan 2011 | A1 |
20110015747 | McManus et al. | Jan 2011 | A1 |
20110112455 | Rocklin | May 2011 | A1 |
20110125266 | Rodgers et al. | May 2011 | A1 |
20110144440 | Cropper et al. | Jun 2011 | A1 |
20110172722 | Verhulst et al. | Jul 2011 | A1 |
20110208306 | Farris | Aug 2011 | A1 |
20110230965 | Schell et al. | Sep 2011 | A1 |
20110245926 | Kitchen | Oct 2011 | A1 |
20110307063 | Schaller et al. | Dec 2011 | A1 |
20120022651 | Akyuz et al. | Jan 2012 | A1 |
20120071977 | Oglaza et al. | Mar 2012 | A1 |
20120071980 | Purcell et al. | Mar 2012 | A1 |
20120089231 | Prestigiacomo | Apr 2012 | A1 |
20120123426 | Quimo | May 2012 | A1 |
20120136442 | Kleiner | May 2012 | A1 |
20120136448 | Seifert et al. | May 2012 | A1 |
20120150241 | Ragab et al. | Jun 2012 | A1 |
20120232552 | Morgenstern Lopez et al. | Sep 2012 | A1 |
20120232664 | Ulrich, Jr. et al. | Sep 2012 | A1 |
20120277861 | Steele et al. | Nov 2012 | A1 |
20120283748 | Ortiz et al. | Nov 2012 | A1 |
20120296171 | Lovell et al. | Nov 2012 | A1 |
20130053863 | Juravic et al. | Feb 2013 | A1 |
20130110239 | Siegal et al. | May 2013 | A1 |
20130116791 | Theofilos | May 2013 | A1 |
20130144391 | Siegal et al. | Jun 2013 | A1 |
20130158667 | Tabor et al. | Jun 2013 | A1 |
20130204374 | Milella, Jr. | Aug 2013 | A1 |
20130238098 | Schaller et al. | Sep 2013 | A1 |
20130282143 | Perkins et al. | Oct 2013 | A1 |
20130304070 | Nelson et al. | Nov 2013 | A1 |
20140058513 | Gahman et al. | Feb 2014 | A1 |
20140067073 | Hauck | Mar 2014 | A1 |
20140163326 | Forsell | Jun 2014 | A1 |
20140163560 | Fenn et al. | Jun 2014 | A1 |
20140235949 | Smith | Aug 2014 | A1 |
20140236296 | Wagner et al. | Aug 2014 | A1 |
20140249629 | Moskowitz et al. | Sep 2014 | A1 |
20140257297 | Koogle, Jr. et al. | Sep 2014 | A1 |
20140257484 | Flower et al. | Sep 2014 | A1 |
20140277481 | Lee et al. | Sep 2014 | A1 |
20140316427 | Yoon et al. | Oct 2014 | A1 |
20150012000 | Siegal et al. | Jan 2015 | A1 |
20150051701 | Glerum et al. | Feb 2015 | A1 |
20150100124 | Whipple | Apr 2015 | A1 |
20150112437 | Davis et al. | Apr 2015 | A1 |
20150112438 | McLean | Apr 2015 | A1 |
20150148908 | Marino et al. | May 2015 | A1 |
20150367487 | Nino et al. | Dec 2015 | A1 |
20160007979 | Bhagat et al. | Jan 2016 | A1 |
20160206442 | Dvorak et al. | Jul 2016 | A1 |
20160287409 | Ziemek | Oct 2016 | A1 |
20160367332 | Shah et al. | Dec 2016 | A1 |
20170007349 | Solar et al. | Jan 2017 | A1 |
20170135704 | Abbasi | May 2017 | A1 |
20170303938 | Rindal et al. | Oct 2017 | A1 |
20190167440 | Lee et al. | Jun 2019 | A1 |
20190216482 | Huffmaster et al. | Jul 2019 | A1 |
20190216612 | Schaller et al. | Jul 2019 | A1 |
20200345401 | McHale et al. | Nov 2020 | A1 |
20210113252 | Ammerman et al. | Apr 2021 | A1 |
20210154024 | Lorang et al. | May 2021 | A1 |
20210169459 | Pacheco-Serrant et al. | Jun 2021 | A1 |
20220031471 | Hessler et al. | Feb 2022 | A1 |
20220110650 | Huffmaster et al. | Apr 2022 | A1 |
20230051745 | Pacheco-Serrant et al. | Feb 2023 | A1 |
20230124332 | Lorang et al. | Apr 2023 | A1 |
Number | Date | Country |
---|---|---|
42 22 121 | Sep 1993 | DE |
197 10 392 | Jul 1999 | DE |
197 10 392 | Jul 1999 | DE |
0 682 910 | Nov 1995 | EP |
1 157 676 | Nov 2001 | EP |
1 157 676 | Nov 2001 | EP |
2900814 | May 2006 | FR |
2 900 814 | Nov 2007 | FR |
2002-28171 | Jan 2002 | JP |
2002-028171 | Jan 2002 | JP |
WO 95025485 | Sep 1995 | WO |
WO 98017190 | Apr 1998 | WO |
WO 98034552 | Aug 1998 | WO |
WO 9834552 | Aug 1998 | WO |
WO 99021500 | May 1999 | WO |
WO 9921500 | May 1999 | WO |
WO 99047058 | Sep 1999 | WO |
WO 00074605 | Dec 2000 | WO |
WO 0074605 | Dec 2000 | WO |
WO 01001895 | Jan 2001 | WO |
WO 03024344 | Mar 2003 | WO |
WO 2005048856 | Jun 2005 | WO |
WO 2006042334 | Apr 2006 | WO |
WO 2006047587 | May 2006 | WO |
WO 2006047587 | May 2006 | WO |
WO 2006072941 | Jul 2006 | WO |
WO 2006072941 | Jul 2006 | WO |
WO 2007009107 | Jan 2007 | WO |
WO 2007079237 | Jul 2007 | WO |
WO 2007100914 | Sep 2007 | WO |
WO 2008021972 | Feb 2008 | WO |
WO 2008036505 | Mar 2008 | WO |
WO 2008036505 | Mar 2008 | WO |
WO 2008063435 | May 2008 | WO |
WO 2008084479 | Jul 2008 | WO |
WO 2008084479 | Jul 2008 | WO |
WO 2008103832 | Aug 2008 | WO |
WO 2008112308 | Sep 2008 | WO |
WO 2010008353 | Jan 2010 | WO |
WO 2010008353 | Jan 2010 | WO |
WO 2011150350 | Dec 2011 | WO |
WO 2012048187 | Apr 2012 | WO |
WO 2012178018 | Dec 2012 | WO |
WO 2013043850 | Mar 2013 | WO |
WO 2014158680 | Oct 2014 | WO |
WO 2019148083 | Aug 2019 | WO |
WO 2019178575 | Sep 2019 | WO |
Entry |
---|
Official Communication in European Application No. 08730402.8, dated Feb. 18, 2013. |
International Search Report and Written Opinion in International Application No. PCT/US2008/054590, dated Aug. 22, 2008. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2008/054590, dated Aug. 28, 2009. |
International Search Report and Written Opinion in International Application No. PCT/US2019/015386, dated May 23, 2019. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2019/015386, dated Aug. 13, 2020. |
International Search Report and Written Opinion in International Application No. PCT/US2019/022632, dated May 30, 2019. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2019/022632, dated Oct. 1, 2020. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2014/019246, dated Sep. 24, 2015. |
Office Communication for U.S. Appl. No. 13/804,847, dated Jul. 13, 2015. |
Office Communication for U.S. Appl. No. 13/804,847, dated Oct. 16, 2015. |
Extended European Search Report for European Patent Application No. 11787510.4, dated Oct. 15, 2013. |
International Search Report and Written Opinion for PCT Patent Application No. PCT/US2011/038377, dated Aug. 25, 2011. |
International Search Report and Written Opinion for PCT Patent Application No. PCT/US2013/068906, dated Feb. 6, 2014. |
International Search Report and Written Opinion in International Application No. PCT/US2014/019246, dated Aug. 19, 2014. |
Office Action dated Jul. 2, 2015 for U.S. Appl. No. 13/803,322. |
Office Action dated Apr. 4, 2016 for U.S. Appl. No. 13/803,322. |
Number | Date | Country | |
---|---|---|---|
Parent | 13803322 | Mar 2013 | US |
Child | 17206771 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15276147 | Sep 2016 | US |
Child | 17206771 | US |